NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
271-285 of 365
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiersDiagnosing Suspected MS: A Review of the Updated Guidelines
Andrew Wilner, MD, FACP, FAAN
Eoin Flanagan, MB, BCh
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiersThe Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action CenterClarity for Schizophrenia: The Latest in Drug Treatment
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action CenterLocked Up in My Own Mind: Challenges in the Criminal Justice System
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiersNew Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiersStudying the Safety of Discontinuing DMTs in MS Older Adults
Andrew Wilner, MD, FACP, FAAN
John R. Corboy, MD
- advertisement
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiersUncovering Disease Progression in Multiple Sclerosis
Sergio Baranzini, PhD
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiersExamining the Correlation Between HIV & Neurocognitive Disorders
Jerome Lisk, MD, MBA, M.S., FAAN
Santosh Kumar, PhD
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
NeuroFrontiersPrescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ashley Baker, MSN, PMHNP
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiersNIH Study Identifies Cause for Long COVID Neurological Symptoms
Charles Turck, PharmD, BCPS, BCCCP
Avindra Nath, MD
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiersDiagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
Charles Turck, PharmD, BCPS, BCCCP
Lokesh Shahani, MD, PhD, MPH, FACP, FASAM
Jerome Lisk, MD, MBA, M.S., FAAN
Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
- advertisement
Music Therapy Improves Schizophrenia Symptoms in the Inpatient Setting
NeuroFrontiersMusic Therapy Improves Schizophrenia Symptoms in the Inpatient Setting
The Cell Death Pathway: Leveraging Glioblastoma Treatments
NeuroFrontiersThe Cell Death Pathway: Leveraging Glioblastoma Treatments
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Dominique Higgins, MD, PhD
Treating BPSD with Cannabinoids: What We Currently Know
NeuroFrontiersTreating BPSD with Cannabinoids: What We Currently Know
Jerome Lisk, MD, MBA, M.S., FAAN
Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
